Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Other Non-Current Liabilities (2023 - 2025)

Historic Other Non-Current Liabilities for CG Oncology (CGON) over the last 2 years, with Q3 2025 value amounting to $3.8 million.

  • CG Oncology's Other Non-Current Liabilities changed N/A to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year change of. This contributed to the annual value of $365000.0 for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, CG Oncology's Other Non-Current Liabilities is $3.8 million.
  • CG Oncology's Other Non-Current Liabilities' 5-year high stood at $3.8 million during Q3 2025, with a 5-year trough of $365000.0 in Q4 2023.